A P-glycoprotein inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ONT-093

Item No. 28758

Technical Information
Formal Name
4-[2-[4-[(1E)-3-ethoxy-1-propen-1-yl]phenyl]-4-[4-[(1-methylethyl)amino]phenyl]-1H-imidazol-5-yl]-N-(1-methylethyl)-benzenamine
CAS Number
216227-54-2
Synonyms
  • OC 144093
Molecular Formula
C32H38N4O
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
λmax
274, 359 nm
SMILES
CCOC/C=C/C1=CC=C(C2=NC(C3=CC=C(NC(C)C)C=C3)=C(C4=CC=C(NC(C)C)C=C4)N2)C=C1
InChi Code
InChI=1S/C32H38N4O/c1-6-37-21-7-8-24-9-11-27(12-10-24)32-35-30(25-13-17-28(18-14-25)33-22(2)3)31(36-32)26-15-19-29(20-16-26)34-23(4)5/h7-20,22-23,33-34H,6,21H2,1-5H3,(H,35,36)/b8-7+
InChi Key
RSJCLODJSVZNQA-BQYQJAHWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    ONT-093 is an orally bioavailable substituted diarylimidazole inhibitor of P-glycoprotein ATPase activity (IC50 = 0.16 µM).1 It reverses drug resistance to doxorubicin (Item No. 15007), vinblastine (Item No. 11762), and paclitaxel (Item No. 10461) in human lymphoma, breast, ovarian, uterine, and colorectal cancer cell lines in vitro (EC50s = 9-38 nM). It is not cytotoxic to 15 normal, non-transformed, or tumor cell lines when used at concentrations up to 100 µM and exhibits weak cytostatic activity (average IC50 = >60 µM). ONT-093 (30 mg/kg) reverses paclitaxel drug resistance in an HCT15 human colon carcinoma mouse xenograft model.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Newman, M.J., Rodarte, J.C., Benbatoul, K.D., et alDiscovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Res. 60(11), 2964-2972 (2000).